NCT03477838CompletedNot Applicable
A Pharmacist-driven Continuous Glucose Monitoring Program for Advanced Diabetes Management in an Uninsured Population
Virginia Commonwealth University2 sites in 1 country28 target enrollmentStarted: April 26, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 28
- Locations
- 2
- Primary Endpoint
- Change in A1c
Study Overview
Brief Summary
This is a pilot study. The purpose is to (1) provide access to continuous glucose monitoring (CGM) to patients (purchased through a grant) and (2) systematically record and analyze the results of the glucose monitoring by the clinical pharmacists at the clinic.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to 89 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •adult 18 years of age or older
- •diagnosis of Type 1 or Type 2 diabetes
- •A1c greater than 8%
- •prescribed basal insulin plus either prandial insulin or a glucagon-like peptide-1 (GLP-1) receptor agonist
Exclusion Criteria
- •pregnant or breast-feeding
- •on dialysis
- •not appropriate for CGM use based on clinical judgment by the investigators
- •patients with limited English proficiency
Outcomes
Primary Outcomes
Change in A1c
Time Frame: Baseline to week 12
Change in A1c will be used to assess glycemic control
Secondary Outcomes
- Medication Changes(Baseline to week 12)
- Glycemic Variability(Baseline to week 12)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management PlatformGlucose Metabolism DisordersDiabetes MellitusPreDiabetesNCT04369833Pusan National University Hospital130
Completed
Phase 1
Evaluation of Continuous Glucose Monitoring in Participants With Type 2 Diabetes Mellitus (MK-0000-258 AM2)Type 2 Diabetes MellitusNCT01537120Merck Sharp & Dohme LLC25
Completed
Not Applicable
Continuous Glucose Monitoring for Hyperglycemia in Critically Ill PatientsCritical IllnessDiabetes MellitusHyperglycemiaHypoglycemiaNCT05442853Malcom Randall VA Medical Center85
Recruiting
Not Applicable
Periodic Continuous Glucose Monitoring in Patients With Type 2 DiabetesType 2 DiabetesNCT05633628Sophiahemmet University400
Completed
Phase 2
Glycemic Effect of Colesevelam HCl (Welchol) in Patients With Type 2 DiabetesType 2 DiabetesNCT00993824HealthPartners Institute21